Stellar Biotechnologies Inc. (SBOTF)

[Wildbilly]

Stellar Biotechnologies: Low Risk Biotech Provider With Significant Upside
Mar. 28, 2014 5:00 AM ET | 9 comments | About: SBOTF
Disclosure: I am long SBOTF. (More...)

Summary

Stellar's main product (KLH) is involved in 20 active clinical trials.
Studies include cures for cancer, Alzheimer's, arthritis and AIDS.
Stellar's valuation is only $125 mm vs. peers valued in the billions.
(Editors' Note: Stellar Biotechnologies trades on the TSX Venture Exchange, symbol KLH.V, with average daily volume of C$350,000.)

Stellar Biotechnologies (OTCQB:SBOTF) (KLH.V) is the world leader in sustainable manufacturing of Keyhole Limpet Hemocyanin (KLH). Although KLH has been known as an important immune-stimulating protein (a substance that naturally induces an immune response) for over 40 years, its role as an ideal carrier molecule for vaccine antigens (substances that promote the generation of antibody and cell-mediated immune responses) against cancers and infectious agents is the basis for the fastest growing new class of drugs known as active immunotherapies.

KLH is currently involved in a mind-bending 20 active human clinical trials where many of the world's finest drug developers are seeking to cure dozens of serious diseases. These include Alzheimer's, Arthritis, Cancer (over 20 different types, including a late stage 3 clinical trial for breast cancer), Lupus, HIV, MS, Asthma, hypertension, etc.

If even one of these new drugs go into production, the world's only sustainable KLH supply is from Stellar; they have revolutionized the KLH industry, turning this vital, natural protein into a renewable, quality resource.

KLH

Keyhole Limpet Hemocyanin (KLH) is a potent immunogenic high-molecular-weight protein; i.e. a substance that naturally induces an immune response. KLH is a highly effective T-dependent carrier protein that induces MHC Class I and Class II-restricted immune responses via antigen presenting cells.

You already know KLH (you just didn't know it)

read on..
http://seekingalpha.com/article/2113983-stellar-biotechnologies-low-risk-biotech-provider-with-significant-upside?ifp=0